RISK-SHARING AGREEMENTS FOR ONCOLOGY DRUGS IN SWEDEN (a)over-cap(sic)" THE NEW STANDARD FOR ACCESS?

被引：0
|
作者：
Olsson, K. [1 ]
Carlqvist, P. [1 ]
机构：
[1] Nord Market Access AB, Stockholm, Sweden
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN391
引用
收藏
页码：S512 / S512
页数：1
相关论文
共 21 条
  • [1] Italian risk-sharing agreements on drugs: are they worthwhile?
    Livio Garattini
    Alessandro Curto
    Katelijne van de Vooren
    The European Journal of Health Economics, 2015, 16 : 1 - 3
  • [2] Italian risk-sharing agreements on drugs: are they worthwhile?
    Garattini, Livio
    Curto, Alessandro
    van de Vooren, Katelijne
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2015, 16 (01): : 1 - 3
  • [3] Innovative patient access schemes for the adoption of new technology: risk-sharing agreements
    Espin, Jaime
    Oliva, Juan
    Manuel Rodriguez-Barrios, Jose
    GACETA SANITARIA, 2010, 24 (06) : 491 - 497
  • [4] COMMUNICATING RISK OF MEDICATION SIDE EFFECTS: HOW RARE IS (A)over-cap (sic) RARE' AND HOW LIKELY IS (a)over-cap(sic) LIKELY'?
    Sawant, R., V
    Sansgiry, S. S.
    VALUE IN HEALTH, 2015, 18 (03) : A85 - A85
  • [5] Global variations in reimbursement of new cancer therapeutics: Improving access through risk-sharing agreements
    Cheema, P. K.
    Gavura, S.
    Godman, B.
    Yeung, L.
    Trudeau, M. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Risk-sharing agreements for innovative drugsA new solution to old problems?
    Gérard de Pouvourville
    The European Journal of Health Economics, 2006, 7 (3) : 155 - 157
  • [7] THE MODEL OF OUTCOMES-BASED RISK SHARING AGREEMENTS APPLIED TO TARGETED DRUGS IN ONCOLOGY
    Rihova, B.
    Demlova, R.
    VALUE IN HEALTH, 2019, 22 : S495 - S495
  • [8] HOW WILL THE NEW NHS CHANGES IN ENGLAND IMPACT THE IMPLEMENTATION OF RISK-SHARING SCHEMES FOR ONCOLOGY TREATMENTS?
    Jeffery, M.
    Assimakopoulos, M.
    White, R.
    VALUE IN HEALTH, 2012, 15 (07) : A287 - A287
  • [9] Lessons learned from the Canadian Fabry Disease Initiative for future risk-sharing and managed access agreements for pharmaceutical and advanced therapies in Canada
    Douglas, Conor M. W.
    Grunebaum, Shir
    HEALTH POLICY, 2024, 143
  • [10] ECONOMIC ANALYSIS OF EVARREST (a)over-cap,(sic) COMPARED WITH STANDARD OF CARE IN SOFT TISSUE AND HEPATIC SURGICAL BLEEDING: A US HOSPITAL PERSPECTIVE
    Corral, M.
    Ferko, N.
    Hogan, A.
    Hollmann, S.
    Jamous, N.
    Batiller, J.
    Kocharian, R.
    VALUE IN HEALTH, 2015, 18 (03) : A51 - A51
123